FDA Adds New Warnings to Dronedarone (Multaq) Label
The analysis reaffirmed the benefits of dronedarone in ATHENA, finding that dronedarone caused a reduction in hospitalizations and was not associated with an increased risk of cardiovascular death, stroke or heart failure. [12-19-2011] The US Food and ...
FDA Further Restricts Use of Sanofi's MultaqWall Street Journal
FDA adds new heart warning to Sanofi's MultaqThe Associated Press
FDA Adds New Heart Warning To Sanofi's MultaqSalon

all 133 news articles »